PharmAbcine Inc.
Clinical-stage biotech developing human monoclonal antibodies for various diseases.
208340 | KO
Overview
Corporate Details
- ISIN(s):
- KR7208340000
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1689번길 70 KT대덕2연구센터 연구2동 2층, 대전광역시
- Website:
- http://pharmabcine.com/
- Sector:
- Manufacturing
Description
PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2019-11-14 00:00 |
분기보고서 (2019.09)
|
Korean | HTML • 1.2 MB | ||
| 2019-10-22 00:00 |
타법인주식및출자증권취득결정
|
Korean | HTML • 18.3 KB | ||
| 2019-09-30 00:00 |
투자판단관련주요경영사항(( TTAC-0001의 재발성 교모세포종 다기관 국제임상(PMC-TTAC-0001_03)에 대한 미국 임상 2상 개시)
|
Korean | HTML • 6.5 KB | ||
| 2019-09-27 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | HTML • 60.7 KB | ||
| 2019-09-02 00:00 |
전환가액의조정(제1회차)
|
Korean | HTML • 10.4 KB | ||
| 2019-08-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 22.1 KB | ||
| 2019-08-28 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | HTML • 80.2 KB | ||
| 2019-08-27 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 22.1 KB | ||
| 2019-08-27 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | HTML • 82.2 KB | ||
| 2019-08-16 00:00 |
기타경영사항(자율공시)(TTAC-0001의 재발성 교모세포종 다기관 국제 임상 (PMC_TTAC-0001_03)에 대한 호주 2상 임상시험 계…
|
Korean | HTML • 5.6 KB | ||
| 2019-08-14 00:00 |
반기보고서 (2019.06)
|
Korean | HTML • 1.1 MB | ||
| 2019-08-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 22.1 KB | ||
| 2019-07-31 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 22.1 KB | ||
| 2019-07-04 00:00 |
주식매수선택권행사
|
Korean | HTML • 18.7 KB | ||
| 2019-06-10 00:00 |
기타경영사항(특허권취득)(자율공시)(Bispecific Antibody Targeting VEGFR-2 and DLL4, and Pharmac…
|
Korean | HTML • 5.5 KB |
Automate Your Workflow. Get a real-time feed of all PharmAbcine Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PharmAbcine Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmAbcine Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
